Stocks
Nektar Therapeutics (NKTR) EV/EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EV/EBITDA | ? | -6.11 | -4.16 | -0.15 | -0.22 | -0.26 | -0.40 | |
| Changes by years, y/y, % | -19% | -32% | -96% | +48% | +17% | |||
Nektar Therapeutics. EV/EBITDA
Nektar Therapeutics. EV/EBITDA, changes, %
Nektar Therapeutics (NKTR) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| EV/EBITDA | ? | 1.32 | 1.08 | -0.29 | -1.05 | -1.65 | -0.40 | |
| Changes by years, y/y, % | -332% | -285% | +28% | -180% | -225% | |||
| Changes by quarters, q/q, % | +1% | -18% | -127% | +259% | +58% | |||
